BCPEM
NVO

Bain Capital Public Equity Management’s Novo Nordisk NVO Stock Holding History

Bain Capital Public Equity Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-503,764
Closed -$13.2M – 27
2019
Q1 		$13.2M Buy
+503,764
New +$12.4M 1.26% 24

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Bain Capital Public Equity Management's NVO Position: Q2 2019 in Review

Bain Capital Public Equity Management sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 503,764 shares — an estimated $13.2M sold.

Bain Capital Public Equity Management first reported a position in NVO in Q1 2019 and held it in 1 quarter. The position peaked at $13.2M in Q1 2019. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

  • Bain Capital Public Equity Management reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
  • Bain Capital Public Equity Management sold 503,764 Novo Nordisk shares in Q2 2019, an estimated $13.2M.
  • Bain Capital Public Equity Management first reported a position in Novo Nordisk in Q1 2019 and held it in 1 quarter.
  • Bain Capital Public Equity Management's Novo Nordisk position peaked at $13.2M in Q1 2019.
  • 559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2019.